Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICA.

作者: Thomas F. Gamage , Charlotte E. Farquhar , Timothy W. Lefever , Julie A. Marusich , Richard C. Kevin

DOI: 10.1124/JPET.117.246983

关键词: CannabinoidPharmacologyCannabinoid receptorChemistryCardiotoxicityCannabinoid receptor type 2HEK 293 cellsSynthetic cannabinoidsReceptorCannabis

摘要: Synthetic cannabinoids are a class of novel psychoactive substances that exhibit high affinity at the cannabinoid type-1 (CB1) receptor and produce effects similar to those Δ-9-tetrahydrocannabinol (THC), primary constituent cannabis. Illicit drug manufacturers continually circumventing laws banning sale synthetic by synthesizing structures doing so with little regard for potential impact on pharmacological toxicological effects. wide range include cardiotoxicity, seizure activity, kidney damage, they can cause death. Six cannabinoids, recently detected in illicit preparations, MMB-FUBINACA, MDMB-FUBINACA, CUMYL-PICA, 5F-CUMYL-PICA, NNEI, MN-18 were assessed for: 1) binding human CB1 CB2 receptors, 2) function [35S]GTPγS cAMP signaling, 3) THC-like mouse discrimination assay. All six exhibited receptors type-2 produced greater maximal than THC signaling. Additionally, all substituted discrimination, suggesting probably possess subjective Notably, methylated analog had higher parent, showing minor structural modifications being introduced have large properties these drugs. This study demonstrates sold used illicitly as substitutes cannabis retaining receptor, exhibiting efficacy THC, producing models relevant humans.

参考文章(61)
Jenny L Wiley, Cannabis: discrimination of "internal bliss"? Pharmacology, Biochemistry and Behavior. ,vol. 64, pp. 257- 260 ,(1999) , 10.1016/S0091-3057(99)00059-3
Jenny Wiley, Julie Marusich, J.W. Huffman, R.L. Balster, Brian Thomas, Hijacking of basic research: The case of synthetic cannabinoids Methods report (RTI Press). ,vol. 2011, ,(2011) , 10.3768/RTIPRESS.2011.OP.0007.1111
Volker Auwärter, Paul I. Dargan, David M. Wood, Synthetic Cannabinoid Receptor Agonists Novel Psychoactive Substances#R##N#Classification, Pharmacology and Toxicology. pp. 317- 343 ,(2013) , 10.1016/B978-0-12-415816-0.00013-4
E. M. Briley, C. C. Felder, K. Mackie, O. Blond, Jaleh Mansouri, K. E. Joyce, R. L. Mitchell, Y. Lai, A. L. Ma, Comparison of the pharmacology and signal transduction of the human cannabinoid CB1 and CB2 receptors. Molecular Pharmacology. ,vol. 48, pp. 443- 450 ,(1995)
Monica J. Barratt, Vince Cakic, Simon Lenton, Patterns of synthetic cannabinoid use in Australia. Drug and Alcohol Review. ,vol. 32, pp. 141- 146 ,(2013) , 10.1111/J.1465-3362.2012.00519.X
Jenny L. Wiley, Julie A. Marusich, Timothy W. Lefever, Kateland R. Antonazzo, Michael T. Wallgren, Ricardo A. Cortes, Purvi R. Patel, Megan Grabenauer, Katherine N. Moore, Brian F. Thomas, AB-CHMINACA, AB-PINACA, and FUBIMINA: Affinity and Potency of Novel Synthetic Cannabinoids in Producing Δ9-Tetrahydrocannabinol–Like Effects in Mice Journal of Pharmacology and Experimental Therapeutics. ,vol. 354, pp. 328- 339 ,(2015) , 10.1124/JPET.115.225326
Tetsudo Kaya, Hiroyuki Iwamura, Hidekazu Suzuki, Takashi Inaba, Yoshifumi Ueda, In vitro and in vivo pharmacological characterization of JTE-907, a novel selective ligand for cannabinoid CB2 receptor. Journal of Pharmacology and Experimental Therapeutics. ,vol. 296, pp. 420- 425 ,(2001)
V M Showalter, M E Abood, D R Compton, B R Martin, Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands. Journal of Pharmacology and Experimental Therapeutics. ,vol. 278, pp. 989- 999 ,(1996)
Torbjörn U. C. Järbe, Chen Li, Subramanian K. Vadivel, Alexandros Makriyannis, Discriminative stimulus functions of methanandamide and ∆9-THC in rats: tests with aminoalkylindoles (WIN55,212-2 and AM678) and ethanol Psychopharmacology. ,vol. 208, pp. 87- 98 ,(2010) , 10.1007/S00213-009-1708-Z